Galapagos promotes Piet Wigerinck to CSO
This article was originally published in Scrip
Executive Summary
Galapagos has named Dr Piet Wigerinck chief scientific officer, responsible for overseeing target and drug discovery efforts and expanding the company's development department. Dr Wigerinck joined Galapagos as senior vice-president of development in April 2008, and before that was vice-president of drug discovery, early development and CM&C at Tibotec.